General Information
Drug ID
DR01439
Drug Name
Belotecan
Synonyms
Belotecan hydrochloride; 213819-48-8; Belotecan; CKD-602; Belotecan HCl; Camtobell hydrochloride; Belotecan (hydrochloride); CKD 602; UNII-01DZ4127G7; 01DZ4127G7; Belotecan hydrochloride (USAN); Belotecan Hydrochloride [USAN]; CHEMBL2107315; DTXSID60175647; BCP28717; HY-13566A; AKOS027420465; API0009359; CS-6955; (S)-4-ethyl-4-hydroxy-11-(2-(isopropylamino)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride; AN-29684; ACM213819488; FT-0662513; D03225; 819C488; J-014022
Drug Type
Small molecular drug
Indication Non-small cell lung cancer [ICD11: 2C25] Phase 3 [1]
Structure
3D MOL 2D MOL
Formula
C25H27N3O4
Canonical SMILES
CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O
InChI
InChI=1S/C25H27N3O4/c1-4-25(31)19-11-21-22-17(12-28(21)23(29)18(19)13-32-24(25)30)15(9-10-26-14(2)3)16-7-5-6-8-20(16)27-22/h5-8,11,14,26,31H,4,9-10,12-13H2,1-3H3/t25-/m0/s1
InChIKey
LNHWXBUNXOXMRL-VWLOTQADSA-N
CAS Number
CAS 256411-32-2
Pharmaceutical Properties Molecular Weight 433.5 Topological Polar Surface Area 91.8
Heavy Atom Count 32 Rotatable Bond Count 5
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
1.6
PubChem CID
6456014
PubChem SID
12015068 , 14907463 , 14907464 , 17194827 , 17397378 , 43529718 , 50913634 , 57371893 , 126681060 , 135252488 , 160687459 , 162255311 , 198969553 , 223664191 , 252166952
ChEBI ID
CHEBI:135702
TTD Drug ID
D0U6ML
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [3]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 ClinicalTrials.gov (NCT00826644) Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
2 Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells. Pharm Res. 2008 Nov;25(11):2601-12.
3 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.